Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Design, Development and Therapy|September 7, 2013
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancerJulius Semenas, Nishtman Dizeyi, Jenny Liao Persson
Current Drug Targets|July 4, 2012
Overcoming drug resistance and treating advanced prostate cancerJulius Semenas, Cinzia Allegrucci, Stephen A Boorjian, et al.
Plos One|November 22, 2013
Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancerMartina Tinzl, Binshen Chen, Shao-Yong Chen, et al.
Plos One|December 19, 2018
Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate CancerMartina Tinzl, Binshen Chen, Shao-Yong Chen, et al.
European Urology Open Science|February 6, 2023
A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord CompressionJohan Wänman, Kasim Abul-Kasim, Julius Semenas, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancerAnna Mandel, Per Larsson, Martuza Sarwar, et al.
Molecular Oncology|December 4, 2020
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration-resistant prostate cancerJulius Semenas, Tianyan Wang, Azharuddin Sajid Syed Khaja, et al.
Cancers|November 11, 2022
Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation TherapyPernilla Wikström, Sofia Halin Bergström, Andreas Josefsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2014
The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancerJulius Semenas, Andreas Hedblom, Regina R Miftakhova, et al.
Cancers|May 13, 2023
Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328Helena Järemo, Julius Semenas, Sofia Halin Bergström, et al.
Pageof 2